Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training
Automatic Oxygen Titration Versus Constant Oxygen Flow Rates During Exercise Training in Hypoxemic People With Chronic Lung Disease - a Randomized, Double-blind, Controlled Cross-over Pilot Study
1 other identifier
interventional
15
1 country
1
Brief Summary
Long-term oxygen therapy is a fundamental treatment modality for patients with chronic hypoxaemic lung disease. Typically, oxygen is administered at a constant flow rate. However, due to fluctuating activity levels, patients' oxygenation status can vary, potentially leading to oxygen desaturation and increased dyspnoea. Emerging evidence suggests that automatic oxygen titration - a method of adjusting oxygen flow in response to current oxygen saturation - may have acute advantages over constant oxygen flow. The primary objective of this study is to investigate the effect of automatic oxygen titration compared to prescribed constant oxygen flow rates on patients' perceived dyspnoea during exercise endurance training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2023
CompletedStudy Start
First participant enrolled
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedAugust 13, 2024
August 1, 2024
1.3 years
August 8, 2023
August 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Dyspnea
Change of dyspnea sensation rated by modified Borg scale (0 to 10) taken before and after exercise training
Day 1 to 5 and 6 to 10
Secondary Outcomes (9)
Change of oxygen saturation (SpO2) during exercise training
Day 1 to 5 and 6 to 10
Change of transcutaneous partial CO2 pressure (TcPCO2) during exercise training
Day 1 to 5 and 6 to 10
Change of heart rate during exercise training
Day 1 to 5 and 6 to 10
Change of capillary partial pressure of CO2 (pCO2) during exercise training
Day 1 to 5 and 6 to 10
Change of capillary partial pressure of O2 (pO2) during exercise training
Day 1 to 5 and 6 to 10
- +4 more secondary outcomes
Study Arms (2)
Excercise Training Order A and B
EXPERIMENTALThe first series of five exercise trainings (A) involves supplemental oxygen therapy, with automatically titrated oxygen flow rates to maintain an oxygen saturation of 90-94% (A). The second series of five exercise trainings employs supplemental oxygen therapy with constant flow rates (B), as prescribed.
Excercise Training Order B and A
EXPERIMENTALThe first series of five exercise trainings employs supplemental oxygen therapy with constant flow rates (B), as prescribed.The second five series of five exercise trainings involves supplemental oxygen therapy, with automatically titrated oxygen flow rates to maintain an oxygen saturation of 90-94% (A).
Interventions
During five exercise training sessions, oxygen therapy is delivered via prescribed constant oxygen flow
During five exercise sessions, oxygen therapy is delivered via an automatically titrated oxygen flow rate to maintain an SpO2 target of 90-94%.
Eligibility Criteria
You may qualify if:
- Chronic lung disease
- Hypoxemia (pO2\< 55mmHg) under room air conditions (rest or during exercise) or SpO2\<88% during exercise
- established Long-term oxygen therapy or given indication for a Long-term oxygen therapy/ supplemental oxygen therapy for exercise
- Age: 18 to 80 years
- Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)
- Written informed consent
You may not qualify if:
- \- Acute exacerbation of underlying pulmonary disease requiring cessation of exercise training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinikum Berchtesgadener Land, Schön Kliniken
Schönau am Königssee, Bavaria, 83471, Germany
Related Publications (3)
Kofod LM, Westerdahl E, Kristensen MT, Brocki BC, Ringbaek T, Hansen EF. Effect of Automated Oxygen Titration during Walking on Dyspnea and Endurance in Chronic Hypoxemic Patients with COPD: A Randomized Crossover Trial. J Clin Med. 2021 Oct 20;10(21):4820. doi: 10.3390/jcm10214820.
PMID: 34768338BACKGROUNDSchneeberger T, Jarosch I, Leitl D, Gloeckl R, Hitzl W, Dennis CJ, Geyer T, Criee CP, Koczulla AR, Kenn K. Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial. Thorax. 2023 Apr;78(4):326-334. doi: 10.1136/thoraxjnl-2020-216509. Epub 2021 Oct 16.
PMID: 34656996BACKGROUNDVivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pepin JL. Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial. Thorax. 2019 Mar;74(3):298-301. doi: 10.1136/thoraxjnl-2018-211967. Epub 2018 Aug 30.
PMID: 30166425BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Rembert Koczulla, Prof. Dr.
Philipps University Marburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The participant and investigator is blinded to the type of oxygen supply (constant flow or automatic titrating flow).
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 8, 2023
First Posted
August 9, 2024
Study Start
August 14, 2023
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
August 13, 2024
Record last verified: 2024-08